HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load
about
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) responseHLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulsesIncreased breadth and depth of cytotoxic T lymphocytes responses against HIV-1-B Nef by inclusion of epitope variant sequencesImproved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsA statistical framework for modeling HLA-dependent T cell response data.HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24.Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans.Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.Impaired replication capacity of acute/early viruses in persons who become HIV controllers.Long-term control of HIV-1 in hemophiliacs carrying slow-progressing allele HLA-B*5101Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control.Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individualsHuman leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native AfricansHIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.HLA-B57 and gender influence the occurrence of tuberculosis in HIV infected people of south India.High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV controlHLA class I allele promiscuity revisited.Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune controlCD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen TypesDefinition of the viral targets of protective HIV-1-specific T cell responsesExpansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted NefLytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypesHLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infectionFitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape.Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapyHLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIVExtensive HLA class I allele promiscuity among viral CTL epitopes.Gag cytotoxic T lymphocyte escape mutations can increase sensitivity of HIV-1 to human TRIM5alpha, linking intrinsic and acquired immunity.Design and preclinical development of a recombinant protein and DNA plasmid mixed format vaccine to deliver HIV-derived T-lymphocyte epitopesImpact of HLA-DRB1 allele polymorphisms on control of HIV infection in a Peruvian MSM cohort.Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates.Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals.Mechanisms involved in the Abacavir-mediated hypersensitivity syndrome.Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopesMaintenance of AP-2 Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.
P2860
Q21131580-DCEF47B8-2B53-43D7-9628-77A016E840C2Q22001527-0B2E1C2F-52C3-4A7F-B091-592D2E6A56D2Q28741616-4429C48D-0693-433C-83FD-60112381C1B3Q28742751-943E3A8E-53F6-4389-9ABB-1F847BFC5AE5Q31133137-8AACC784-C951-4B4E-9C09-BA563CFDB0A9Q33299493-CCA5DC1C-5416-47DC-AA7A-A81261F1FE20Q33313878-76394FE2-7EA6-4F15-8F6A-3AC92D7DE69CQ33399724-2B83C6C2-AF22-4181-8A6B-3953A1A3F8C1Q33648970-22B76D24-2415-49FE-91AD-67BCFF8A8006Q33963989-63E1CBAA-9C15-4319-BF3A-97C390C28B17Q33966626-35BBDC0B-191F-4566-9499-A02EA7F383F7Q33991948-D241EF2E-614F-4926-97E1-EB0FB984FB5AQ34435052-70A0EFA6-B7BF-4FE8-801F-0F80DC7FDBD4Q34630184-8C2EE085-AD97-4E07-8C91-CACB636596A6Q34651577-F2424682-9C59-4692-B457-DF3FD4B44AAFQ34653619-EB62AFB4-A0B0-480F-8709-0A83171D5676Q35184356-4C7B14F5-ABA3-4D60-BE44-6D74C693FB9FQ35192655-55CDEB80-1608-414B-A9A7-4BBD826C6F9EQ35301640-8851CC49-8478-4E41-A796-5FC7F8522724Q35579689-EF71F96C-87CC-4D9E-AA5F-63ED2B2FB0D3Q35665876-1ADC9287-D05A-4B02-A441-8D4136AC5F9EQ35797743-23E277B5-BD94-4993-A07A-DEC8B754B824Q35800157-D64311DD-0DD3-4B69-8A4E-B22FB1D70D8EQ35849445-2F40A4C3-C2A2-450D-8B3A-51502B4FB9E0Q35857401-EB05BCB1-CC8F-4173-926E-AF62C03A244DQ36014520-063ACEA8-7C97-4AA5-A452-CDC43C1EFF1BQ36086336-5ABCBF61-8AB9-4516-9A66-9D3887F36FEBQ36315529-92382DCD-296A-4140-8809-34F2F73898F4Q36746882-FD00B2D0-C90B-4D04-AD07-EEF7CEFDB5AFQ36748059-F813CD21-17BF-4A1C-8862-1D3BB9BFCF6AQ36910003-D6A44C75-2A6A-4FBD-8F4E-788D419D93A6Q37066721-3CE6A4A6-5005-423C-B16F-D8FB8140AA65Q38959897-8A75DEE4-416D-4BAF-B974-63DE93B3FE32Q39794217-BC25ED5B-4900-44F6-97D0-664BD32F4116Q40135114-04C3C4E6-33A2-4B4E-ACF9-C0D7F8A48836Q42100401-9F8B32AC-71BB-4ABC-973D-F11C543EBC85Q42187290-F4E04E04-1801-41BD-ADB9-B79A241DDDB9Q42392300-A99D82B4-23E7-411C-BED6-A4F95F8E0684Q42741818-D21A0A8B-E49A-4F3F-9A43-77CA4C27B4C4Q47296340-49470C36-082B-4CEF-A0A5-CEEBFF5C1EC3
P2860
HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
HLA-B63 presents HLA-B57/B58-r ...... an immunodeficiency virus load
@ast
HLA-B63 presents HLA-B57/B58-r ...... an immunodeficiency virus load
@en
type
label
HLA-B63 presents HLA-B57/B58-r ...... an immunodeficiency virus load
@ast
HLA-B63 presents HLA-B57/B58-r ...... an immunodeficiency virus load
@en
prefLabel
HLA-B63 presents HLA-B57/B58-r ...... an immunodeficiency virus load
@ast
HLA-B63 presents HLA-B57/B58-r ...... an immunodeficiency virus load
@en
P2093
P2860
P50
P1433
P1476
HLA-B63 presents HLA-B57/B58-r ...... an immunodeficiency virus load
@en
P2093
Alysse G Wurcel
Caitlyn H Linde
Eric S Daar
Eunice Pae
Francesco Marincola
Hannah S Hewitt
Kaori Sango
M Anne St John
Margaret E Feeney
Mathias Lichterfeld
P2860
P304
10218-10225
P356
10.1128/JVI.79.16.10218-10225.2005
P407
P50
P577
2005-08-01T00:00:00Z